000 | 02019 a2200565 4500 | ||
---|---|---|---|
005 | 20250516213538.0 | ||
264 | 0 | _c20150512 | |
008 | 201505s 0 0 eng d | ||
022 | _a1473-5741 | ||
024 | 7 |
_a10.1097/CAD.0000000000000126 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCéruse, Philippe | |
245 | 0 | 0 |
_aA pyriform sinus cancer organ preservation strategy comprising induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil, followed by potentiated radiotherapy: a multicenter, retrospective study. _h[electronic resource] |
260 |
_bAnti-cancer drugs _cSep 2014 |
||
300 |
_a970-5 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aDocetaxel |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInduction Chemotherapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Recurrence, Local |
650 | 0 | 4 | _aOrgan Sparing Treatments |
650 | 0 | 4 |
_aParanasal Sinus Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aPyriform Sinus _xpathology |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aTaxoids _xadministration & dosage |
700 | 1 | _aCosmidis, Alain | |
700 | 1 | _aBelot, Aurélien | |
700 | 1 | _aRabilloud, Muriel | |
700 | 1 | _aFuchsmann, Carine | |
700 | 1 | _aPoupart, Marc | |
700 | 1 | _aRamade, Antoine | |
700 | 1 | _aTartas, Sophie | |
700 | 1 | _aFavrel, Véronique | |
700 | 1 | _aPommier, Pascal | |
700 | 1 | _aZrounba, Philippe | |
700 | 1 | _aFayette, Jérôme | |
773 | 0 |
_tAnti-cancer drugs _gvol. 25 _gno. 8 _gp. 970-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/CAD.0000000000000126 _zAvailable from publisher's website |
999 |
_c23845745 _d23845745 |